{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:10:27Z","timestamp":1773061827068,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.biologicals.2013.06.001","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T08:08:30Z","timestamp":1374739710000},"page":"450-457","source":"Crossref","is-referenced-by-count":16,"title":["WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21\u201323 February 2012"],"prefix":"10.1016","volume":"41","author":[{"given":"Dennis W.","family":"Trent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Minor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeranart","family":"Jivapaisarnpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2013.06.001_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.biologicals.2013.06.001_bib2","series-title":"Vaccines","first-page":"311","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2008"},{"key":"10.1016\/j.biologicals.2013.06.001_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMp058263","article-title":"Control of Japanese encephalitis\u2013within our grasp?","volume":"355","author":"Solomon","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.biologicals.2013.06.001_bib5","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib6","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1016\/j.vaccine.2007.05.034","article-title":"WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006","volume":"25","author":"Ferguson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib7","series-title":"Recommendations for Japanese encephalitis vaccine (inactivated) for human use (Revised 2007)","year":"2011"},{"key":"10.1016\/j.biologicals.2013.06.001_bib8","series-title":"Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use","year":"2002"},{"key":"10.1016\/j.biologicals.2013.06.001_bib9","series-title":"Virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.biologicals.2013.06.001_bib10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.vaccine.2010.12.108","article-title":"Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib11","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose\u2013response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals: Journal of the International Association of Biological Standardization"},{"key":"10.1016\/j.biologicals.2013.06.001_bib13","first-page":"1","article-title":"Prevention Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report Recommendations and reports\/Centers for Disease Control"},{"key":"10.1016\/j.biologicals.2013.06.001_bib14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1099\/vir.0.013631-0","article-title":"Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951","volume":"91","author":"Schuh","year":"2010","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib16","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1743-422X-8-449","article-title":"Emergence of Japanese encephalitis virus genotype V in the Republic of Korea","volume":"8","author":"Takhampunya","year":"2011","journal-title":"Virology Journal"},{"key":"10.1016\/j.biologicals.2013.06.001_bib18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1099\/vir.0.82185-0","article-title":"Molecular epidemiological analysis of Japanese encephalitis virus in China","volume":"88","author":"Wang","year":"2007","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1743-422X-7-345","article-title":"Identification and isolation of Genotype-I Japanese encephalitis virus from encephalitis patients","volume":"7","author":"Wang","year":"2010","journal-title":"Virology Journal"},{"key":"10.1016\/j.biologicals.2013.06.001_bib20","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1128\/JVI.00825-11","article-title":"Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia","volume":"85","author":"Pan","year":"2011","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib21","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib23","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib24","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2000.62.480","article-title":"Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF\/JE SA14\u201314\u20132), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes","volume":"62","author":"Bhatt","year":"2000","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.biologicals.2013.06.001_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2006.75.659","article-title":"Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever\/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE)","volume":"75","author":"Reid","year":"2006","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.biologicals.2013.06.001_bib27","first-page":"584","article-title":"Studies on Culex tritaeniorhynchus and Culex pipiens quinquefascitatus infected orally by Japanese encephalitis SA14-14-2 vaccine virus","volume":"21","author":"Zhang","year":"2005","journal-title":"Chinese Journal of Zoonoses"},{"key":"10.1016\/j.biologicals.2013.06.001_bib28","first-page":"419","article-title":"Biological and molecular characteristics of live attenuated Japanese encephalitis vaccine viru strain SA14-14-2 inoculated intrathoracically to Culex tritaniorhynchus","volume":"20","author":"Liu","year":"2007","journal-title":"China Journal of Biology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib29","first-page":"344","article-title":"Research on Culex tritaeniorhynchus and Culex pipiens quinquefasciatus intrathoracically infected with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain","volume":"19","author":"Zhang","year":"2005","journal-title":"Chinese Journal of Experimental and Clinical Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib30","first-page":"279","article-title":"Observations on the replication of virus and stability of virulence in Culex tritaeniorhynchus after intrathoracically inoculation with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain","volume":"23","author":"Feng","year":"2007","journal-title":"Chinese Journal of Zoonoses"},{"key":"10.1016\/j.biologicals.2013.06.001_bib31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.vaccine.2008.01.021","article-title":"A\u00a05-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses","volume":"26","author":"Sohn","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case\u2013control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2013.06.001_bib33","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case\u2013control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib34","first-page":"242","article-title":"Global Advisory Committee on Vaccine Safety, 9\u201310 June 2005","volume":"80","year":"2005","journal-title":"Weekly Epidemiological Record"},{"key":"10.1016\/j.biologicals.2013.06.001_bib35","unstructured":"Guidelines on the quality, safety and efficacy of dengue vaccines (live, tetravalent) (adopted, 2011). WHO Expert Committee on Biological Standardization. Geneva: World Health Organization."},{"key":"10.1016\/j.biologicals.2013.06.001_bib36","unstructured":"Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines (adopted, 2010). WHO Expert Committee on Biological Standardization. Geneva: World Health Organization. http:\/\/www.who.int\/biologicals\/vaccines\/yellow_fever\/en\/index.html."},{"key":"10.1016\/j.biologicals.2013.06.001_bib37","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JVI.76.4.1932-1943.2002","article-title":"Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines","volume":"76","author":"Monath","year":"2002","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biologicals.2013.06.001_bib38","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.biologicals.2013.06.001_bib40","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2012.02.005","article-title":"Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine","volume":"30","author":"Desai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib41","first-page":"9","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children","author":"Feroldi","year":"2013","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.biologicals.2013.06.001_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4161\/hv.20071","article-title":"Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12\u201318 months: randomized, controlled phase 3 immunogenicity and safety trial","volume":"8","author":"Feroldi","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.biologicals.2013.06.001_bib43","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.biologicals.2013.06.001_bib44","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4161\/hv.6.11.12854","article-title":"Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity","volume":"6","author":"Nasveld","year":"2010","journal-title":"Human Vaccine"},{"key":"10.1016\/j.biologicals.2013.06.001_bib46","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T17:17:26Z","timestamp":1596215846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105613000596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1045105613000596"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.06.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}